Format

Send to

Choose Destination
J Neuropsychiatry Clin Neurosci. 2000 Winter;12(1):40-3.

Treatment of dementia-associated agitation with gabapentin.

Author information

1
Department of Psychiatry and the Neurobehavior and Alzheimer's Disease Center, Beth Israel Medical Center, New York, NY 10003, USA.

Abstract

The authors describe the use of gabapentin in the treatment of 4 outpatients with dementia-associated agitation. On the basis of clinical case reports and the Overt Agitation Severity Scale, all 4 patients had reduced agitation with gabapentin. Three of 4 patients were successfully titrated to a full dose of 2,400mg/day. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia.

PMID:
10678511
DOI:
10.1176/jnp.12.1.40
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center